MDGL

454.22

2.76% 12.22

시간 외 거래: 454.22

Madrigal Pharmaceuticals Inc (MDGL)

개요 뉴스 가격 이력 옵션 체인 Financials MDGL 왜 하락? 토론 예측 주식 분할

전일 마감가:

$442.00

열려 있는:

$442.64

하루 거래량:

281.17K

Relative Volume:

0.83

시가총액:

$10.42B

수익:

$958.40M

순이익/손실:

$-288.28M

주가수익비율:

-35.31

EPS:

-12.8641

순현금흐름:

$-193.02M

1주 성능:

+3.53%

1개월 성능:

+3.97%

6개월 성능:

+3.25%

1년 성능:

+33.29%

1일 변동 폭

$439.68

$460.00

1주일 범위

$427.76

$460.00

52주 변동 폭

$265.00

$615.00

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

명칭

Madrigal Pharmaceuticals Inc

부문

Healthcare (1114)

산업

Biotechnology (621)

전화

404-380-9263

주소

200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA

직원

915

트위터

@MadrigalPharma

다음 수익 날짜

2024-10-31

최신 SEC 제출 서류

MDGL's Discussions on Twitter

Compare MDGL vs VRTX, REGN, ARGX, ALNY, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
MDGL Madrigal Pharmaceuticals Inc	454.22	10.14B	958.40M	-288.28M	-193.02M	-12.86
VRTX Vertex Pharmaceuticals Inc	458.05	114.72B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	737.45	78.67B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	684.50	42.38B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	311.10	41.75B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	282.72	31.33B	5.36B	287.73M	924.18M	2.5229

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-01-28	개시	Barclays	Overweight
2026-01-06	다운그레이드	Wolfe Research	Outperform → Peer Perform
2025-11-05	업그레이드	Cantor Fitzgerald	Neutral → Overweight
2025-11-03	업그레이드	BofA Securities	Underperform → Neutral
2025-10-15	개시	Truist	Buy
2025-09-04	재개	H.C. Wainwright	Buy
2025-02-28	업그레이드	B. Riley Securities	Neutral → Buy
2025-02-27	재확인	H.C. Wainwright	Buy
2024-06-28	개시	Cantor Fitzgerald	Neutral
2024-06-11	개시	Wolfe Research	Outperform
2024-04-22	개시	BofA Securities	Underperform
2024-03-15	업그레이드	B. Riley Securities	Sell → Neutral
2024-03-06	개시	Citigroup	Buy
2024-02-26	다운그레이드	B. Riley Securities	Neutral → Sell
2022-12-20	재확인	Oppenheimer	Outperform
2022-12-19	재확인	H.C. Wainwright	Buy
2022-12-19	재확인	Piper Sandler	Overweight
2022-12-19	업그레이드	Raymond James	Underperform → Mkt Perform
2022-07-08	다운그레이드	B. Riley Securities	Buy → Neutral
2021-10-07	개시	Jefferies	Buy
2021-08-06	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-05-20	재개	Goldman	Buy
2020-11-24	재개	Evercore ISI	Outperform
2020-11-06	재확인	H.C. Wainwright	Buy
2020-07-31	개시	Piper Sandler	Overweight
2020-06-05	개시	BMO Capital Markets	Market Perform
2020-05-05	개시	Chardan Capital Markets	Buy
2020-01-30	개시	Canaccord Genuity	Buy
2020-01-09	업그레이드	UBS	Neutral → Buy
2019-11-07	재확인	H.C. Wainwright	Buy
2019-06-25	개시	Stifel	Hold
2019-06-10	업그레이드	B. Riley FBR	Neutral → Buy
2019-02-28	재확인	H.C. Wainwright	Buy
2019-02-22	개시	SVB Leerink	Outperform
2019-01-23	개시	UBS	Neutral
2018-12-14	개시	Wolfe Research	Outperform
2018-12-12	개시	B. Riley FBR	Neutral
2018-11-19	다운그레이드	Raymond James	Mkt Perform → Underperform
2018-11-16	업그레이드	Evercore ISI	In-line → Outperform
2018-09-04	개시	Citigroup	Buy
2018-08-06	다운그레이드	Goldman	Buy → Neutral
2018-06-28	개시	Raymond James	Mkt Perform

모두보기

Madrigal Pharmaceuticals Inc 주식(MDGL)의 최신 뉴스

04:25 AM

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

04:25 AM

04:05 AM

Seven new Madrigal hires get stock awards that vest over 4 years - Stock Titan

04:05 AM

06:00 AM

Groupama Asset Managment Sells 13,447 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

06:00 AM

Mar 18, 2026

Madrigal grants inducement awards to five employees - MSN

Mar 18, 2026

Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge - MSN

Mar 18, 2026

2,600 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Bamco Inc. NY - MarketBeat

Mar 17, 2026

Mar 16, 2026

Iron Triangle Partners LP Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 16, 2026

First Light Asset Management LLC Takes Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Mar 16, 2026

Mar 15, 2026